| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.728 | 0.005 | 0.786 | Anticonvulsant | 0.786 0.004 DBMET01540 | DBMET01540 | |
| 0.715 | 0.002 | 0.715 | GABA C receptor agonist | 0.715 0.002 DBMET01540 | ||
| 0.637 | 0.011 | 0.637 | 5 Hydroxytryptamine release stimulant | 0.532 0.023 DBMET01540 | ||
| 0.606 | 0.002 | 0.606 | Succinate dehydrogenase inhibitor | 0.498 0.003 DBMET01540 | ||
| 0.572 | 0.023 | 0.572 | Aldehyde oxidase inhibitor | 0.476 0.036 DBMET01540 | ||
| 0.545 | 0.002 | 0.545 | GABA aminotransferase inhibitor | 0.313 0.003 DBMET01540 | ||
| 0.541 | 0.004 | 0.541 | Tyrosine 3 hydroxylase inhibitor | 0.541 0.004 DBMET01540 | ||
| 0.553 | 0.025 | 0.58 | Cholesterol antagonist | 0.58 0.021 DBMET01540 | DBMET01540 | |
| 0.53 | 0.003 | 0.53 | Glutamate dehydrogenase inhibitor | 0.53 0.003 DBMET01540 | ||
| 0.514 | 0.045 | 0.791 | Analgesic | 0.791 0.006 DBMET01540 | DBMET01540 | |
| 0.472 | 0.012 | 0.472 | Peroxidase inhibitor | 0.405 0.02 DBMET01540 | ||
| 0.472 | 0.017 | 0.472 | Platelet antagonist | 0.449 0.019 DBMET01540 | ||
| 0.46 | 0.017 | 0.46 | Superoxide dismutase inhibitor | 0.419 0.024 DBMET01540 | ||
| 0.479 | 0.039 | 0.479 | 5 Hydroxytryptamine release inhibitor | 0.426 0.063 DBMET01540 | ||
| 0.436 | 0.008 | 0.436 | Thrombolytic | 0.386 0.013 DBMET01540 | ||
| 0.442 | 0.017 | 0.442 | Interleukin 2 agonist | 0.442 0.017 DBMET01540 | ||
| 0.426 | 0.004 | 0.426 | Porphobilinogen synthase inhibitor | 0.426 0.004 DBMET01540 | ||
| 0.413 | 0.004 | 0.413 | Alcohol oxidase inhibitor | 0.413 0.004 DBMET01540 | ||
| 0.457 | 0.054 | 0.457 | Antibacterial | 0.282 0.149 DBMET01540 | ||
| 0.451 | 0.049 | 0.451 | Histamine release inhibitor | 0.41 0.071 DBMET01540 | ||
| 0.403 | 0.015 | 0.403 | Growth hormone agonist | 0.377 0.019 DBMET01540 | ||
| 0.388 | 0.004 | 0.388 | Ferrochelatase inhibitor | 0.388 0.004 DBMET01540 | ||
| 0.431 | 0.053 | 0.431 | Immunosuppressant | 0.291 0.12 DBMET01540 | ||
| 0.42 | 0.044 | 0.42 | Immunostimulant | 0.396 0.051 DBMET01540 | ||
| 0.414 | 0.04 | 0.414 | Immunomodulator | 0.246 0.118 DBMET01540 | ||
| 0.376 | 0.005 | 0.376 | Aminopeptidase B inhibitor | 0.334 0.007 DBMET01540 | ||
| 0.388 | 0.018 | 0.388 | Anesthetic general | 0.323 0.028 DBMET01540 | ||
| 0.381 | 0.018 | 0.381 | 5 Hydroxytryptamine uptake stimulant | 0.381 0.018 DBMET01540 | ||
| 0.367 | 0.01 | 0.367 | Protein kinase stimulant | 0.304 0.016 DBMET01540 | ||
| 0.361 | 0.011 | 0.361 | Alpha-N-acetylglucosaminidase inhibitor | 0.361 0.011 DBMET01540 | ||
| 0.374 | 0.025 | 0.374 | DNA synthesis inhibitor | 0.326 0.036 DBMET01540 | ||
| 0.369 | 0.028 | 0.369 | Insulysin inhibitor | 0.345 0.036 DBMET01540 | ||
| 0.387 | 0.053 | 0.387 | Antithrombotic | 0.371 0.057 DBMET01540 | ||
| 0.36 | 0.026 | 0.36 | Interleukin agonist | 0.36 0.026 DBMET01540 | ||
| 0.324 | 0.003 | 0.324 | Aminopeptidase I inhibitor | 0.25 0.004 DBMET01540 | ||
| 0.324 | 0.004 | 0.324 | Ornithine carbamoyltransferase inhibitor | 0.267 0.005 DBMET01540 | ||
| 0.349 | 0.04 | 0.349 | Sodium/bile acid cotransporter inhibitor | 0.349 0.04 DBMET01540 | ||
| 0.376 | 0.069 | 0.376 | Transcription factor NF kappa B inhibitor | 0.257 0.122 DBMET01540 | ||
| 0.355 | 0.053 | 0.355 | Apoptosis antagonist | 0.283 0.098 DBMET01540 | ||
| 0.305 | 0.004 | 0.305 | Argininosuccinate synthase inhibitor | 0.305 0.004 DBMET01540 | ||
| 0.31 | 0.016 | 0.31 | Bone formation stimulant | 0.15 0.059 DBMET01540 | ||
| 0.328 | 0.039 | 0.328 | Angiogenesis stimulant | 0.298 0.05 DBMET01540 | ||
| 0.302 | 0.018 | 0.302 | Phospholipase C inhibitor | 0.271 0.021 DBMET01540 | ||
| 0.296 | 0.015 | 0.296 | Antipruritic | 0.138 0.109 DBMET01540 | ||
| 0.282 | 0.011 | 0.282 | Cell adhesion inhibitor | 0.167 0.037 DBMET01540 | ||
| 0.277 | 0.007 | 0.277 | Catalase inhibitor | 0.255 0.008 DBMET01540 | ||
| 0.272 | 0.006 | 0.272 | Phosphofructokinase-1 inhibitor | 0.272 0.006 DBMET01540 | ||
| 0.297 | 0.035 | 0.297 | Gastrin inhibitor | 0.272 0.056 DBMET01540 | ||
| 0.279 | 0.017 | 0.279 | Neurotensin receptor agonist | 0.249 0.021 DBMET01540 | ||
| 0.29 | 0.029 | 0.29 | Peptidyltransferase inhibitor | 0.29 0.029 DBMET01540 | ||
| 0.266 | 0.009 | 0.266 | Adenylate kinase inhibitor | 0.266 0.009 DBMET01540 | ||
| 0.367 | 0.111 | 0.367 | Cyclophilin D inhibitor | |||
| 0.305 | 0.051 | 0.305 | Hypoglycemic | 0.222 0.095 DBMET01540 | ||
| 0.258 | 0.004 | 0.258 | Glutamate decarboxylase inhibitor | 0.258 0.004 DBMET01540 | ||
| 0.252 | 0.003 | 0.252 | Aconitate hydratase inhibitor | 0.252 0.003 DBMET01540 | ||
| 0.283 | 0.039 | 0.283 | Calpain inhibitor | 0.234 0.081 DBMET01540 | ||
| 0.25 | 0.006 | 0.25 | GABA C receptor antagonist | 0.25 0.006 DBMET01540 | ||
| 0.249 | 0.023 | 0.249 | Phospholipase A2 inhibitor | 0.204 0.04 DBMET01540 | ||
| 0.232 | 0.008 | 0.232 | Photosensitizer | 0.218 0.01 DBMET01540 | ||
| 0.324 | 0.101 | 0.324 | GABA C receptor rho-3 antagonist | 0.324 0.101 DBMET01540 | ||
| 0.226 | 0.003 | 0.226 | Fumarate hydratase inhibitor | 0.226 0.003 DBMET01540 | ||
| 0.231 | 0.012 | 0.231 | Nav1.4 sodium channel blocker | 0.228 0.013 DBMET01540 | ||
| 0.237 | 0.019 | 0.237 | Cell wall synthesis inhibitor | 0.177 0.042 DBMET01540 | ||
| 0.223 | 0.006 | 0.223 | Adenylate cyclase stimulant | 0.223 0.006 DBMET01540 | ||
| 0.275 | 0.064 | 0.275 | Tumour necrosis factor alpha release inhibitor | |||
| 0.215 | 0.004 | 0.215 | Ornithine decarboxylase inhibitor | 0.183 0.005 DBMET01540 | ||
| 0.251 | 0.042 | 0.251 | Non-steroidal antiinflammatory agent | 0.147 0.119 DBMET01540 | ||
| 0.213 | 0.007 | 0.213 | Carbamoyl phosphate synthetase inhibitor | 0.213 0.007 DBMET01540 | ||
| 0.296 | 0.091 | 0.296 | Vasodilator, coronary | 0.271 0.114 DBMET01540 | ||
| 0.214 | 0.009 | 0.214 | Triose-phosphate isomerase inhibitor | 0.214 0.009 DBMET01540 | ||
| 0.217 | 0.014 | 0.217 | GABA receptor agonist | 0.1 0.077 DBMET01540 | ||
| 0.208 | 0.006 | 0.208 | Phenylalanine 4-hydroxylase inhibitor | 0.208 0.006 DBMET01540 | ||
| 0.233 | 0.034 | 0.233 | Diuretic | 0.201 0.044 DBMET01540 | ||
| 0.229 | 0.031 | 0.229 | Thiol protease inhibitor | 0.132 0.093 DBMET01540 | ||
| 0.236 | 0.042 | 0.236 | Anticoagulant | 0.196 0.054 DBMET01540 | ||
| 0.196 | 0.004 | 0.196 | Glycine receptor agonist | 0.196 0.004 DBMET01540 | ||
| 0.195 | 0.008 | 0.212 | Carbonic anhydrase stimulant | 0.212 0.007 DBMET01540 | DBMET01540 | |
| 0.233 | 0.045 | 0.233 | Insulin sensitizer | 0.215 0.06 DBMET01540 | ||
| 0.207 | 0.02 | 0.207 | Toll-Like receptor 2 antagonist | 0.207 0.02 DBMET01540 | ||
| 0.185 | 0.002 | 0.185 | Carboxypeptidase B inhibitor | 0.073 0.003 DBMET01540 | ||
| 0.286 | 0.104 | 0.286 | Vasodilator, peripheral | 0.244 0.132 DBMET01540 | ||
| 0.203 | 0.026 | 0.211 | Cholesterol synthesis inhibitor | 0.211 0.024 DBMET01540 | DBMET01540 | |
| 0.192 | 0.017 | 0.192 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.192 0.017 DBMET01540 | ||
| 0.244 | 0.07 | 0.244 | Hypolipemic | 0.159 0.128 DBMET01540 | ||
| 0.182 | 0.011 | 0.182 | GABA C receptor rho-1 antagonist | 0.182 0.011 DBMET01540 | ||
| 0.175 | 0.005 | 0.175 | Aminopeptidase microsomal inhibitor | 0.123 0.012 DBMET01540 | ||
| 0.187 | 0.017 | 0.187 | Mucolytic | 0.187 0.017 DBMET01540 | ||
| 0.201 | 0.032 | 0.201 | Arachidonic acid antagonist | 0.195 0.038 DBMET01540 | ||
| 0.174 | 0.005 | 0.174 | Macrophage elastase inhibitor | 0.096 0.009 DBMET01540 | ||
| 0.216 | 0.048 | 0.216 | Amyloid beta precursor protein antagonist | |||
| 0.233 | 0.068 | 0.233 | Interleukin antagonist | 0.194 0.087 DBMET01540 | ||
| 0.19 | 0.025 | 0.19 | Cathepsin H inhibitor | 0.165 0.037 DBMET01540 | ||
| 0.178 | 0.019 | 0.178 | Vanilloid 1 agonist | 0.168 0.024 DBMET01540 | ||
| 0.165 | 0.006 | 0.165 | NMDA receptor agonist | 0.153 0.008 DBMET01540 | ||
| 0.223 | 0.069 | 0.223 | Psychostimulant | 0.199 0.08 DBMET01540 | ||
| 0.157 | 0.004 | 0.157 | GABA B receptor agonist | 0.157 0.004 DBMET01540 | ||
| 0.161 | 0.008 | 0.161 | Biliverdin reductase inhibitor | 0.161 0.008 DBMET01540 | ||
| 0.245 | 0.093 | 0.245 | Spasmolytic | 0.243 0.094 DBMET01540 | ||
| 0.163 | 0.013 | 0.163 | Interleukin 1 beta converting enzyme inhibitor | 0.149 0.018 DBMET01540 | ||
| 0.158 | 0.008 | 0.158 | Glutamate release inhibitor | 0.135 0.014 DBMET01540 | ||
| 0.154 | 0.005 | 0.154 | Aminopeptidase N inhibitor | 0.102 0.013 DBMET01540 | ||
| 0.153 | 0.004 | 0.153 | Glutamate (mGluR6) antagonist | 0.153 0.004 DBMET01540 | ||
| 0.166 | 0.017 | 0.166 | Prolactin inhibitor | 0.166 0.017 DBMET01540 | ||
| 0.184 | 0.037 | 0.184 | Calcium channel blocker | 0.176 0.041 DBMET01540 | ||
| 0.166 | 0.02 | 0.166 | HIV-1 integrase (Overall Integration) inhibitor | 0.148 0.026 DBMET01540 | ||
| 0.162 | 0.019 | 0.162 | Cathepsin G inhibitor | 0.133 0.024 DBMET01540 | ||
| 0.317 | 0.176 | 0.317 | Caspase 9 stimulant | 0.293 0.201 DBMET01540 | ||
| 0.197 | 0.058 | 0.197 | Lipocortins synthesis antagonist | 0.197 0.058 DBMET01540 | ||
| 0.148 | 0.009 | 0.148 | Acyl-CoA dehydrogenase inhibitor | 0.148 0.009 DBMET01540 | ||
| 0.22 | 0.083 | 0.22 | Free radical scavenger | 0.163 0.131 DBMET01540 | ||
| 0.146 | 0.01 | 0.146 | Calcium channel L-type blocker | |||
| 0.162 | 0.026 | 0.162 | Heat shock protein 70 antagonist | 0.149 0.047 DBMET01540 | ||
| 0.164 | 0.03 | 0.164 | Expectorant | 0.164 0.03 DBMET01540 | ||
| 0.137 | 0.003 | 0.137 | Lysine carboxypeptidase inhibitor | 0.137 0.003 DBMET01540 | ||
| 0.145 | 0.011 | 0.145 | Toll-Like receptor 2 agonist | 0.112 0.014 DBMET01540 | ||
| 0.168 | 0.036 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | 0.168 0.036 DBMET01540 | ||
| 0.22 | 0.089 | 0.22 | Neuropeptide Y2 antagonist | 0.189 0.14 DBMET01540 | ||
| 0.166 | 0.036 | 0.166 | Cyclooxygenase 3 inhibitor | 0.166 0.036 DBMET01540 | ||
| 0.13 | 0.002 | 0.13 | Carboxypeptidase B2 inhibitor | 0.031 0.003 DBMET01540 | ||
| 0.13 | 0.002 | 0.131 | Membrane dipeptidase inhibitor | 0.131 0.002 DBMET01540 | DBMET01540 | |
| 0.156 | 0.029 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.156 0.029 DBMET01540 | ||
| 0.154 | 0.027 | 0.154 | Protease inhibitor | 0.127 0.043 DBMET01540 | ||
| 0.153 | 0.027 | 0.153 | Carbonic anhydrase III inhibitor | 0.127 0.04 DBMET01540 | ||
| 0.206 | 0.08 | 0.206 | Nitric-oxide synthase stimulant | 0.206 0.08 DBMET01540 | ||
| 0.138 | 0.012 | 0.138 | Interferon agonist | 0.124 0.016 DBMET01540 | ||
| 0.156 | 0.033 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.156 0.033 DBMET01540 | ||
| 0.146 | 0.023 | 0.146 | DOPA decarboxylase inhibitor | 0.146 0.023 DBMET01540 | ||
| 0.14 | 0.018 | 0.14 | Cell adhesion molecule inhibitor | 0.114 0.026 DBMET01540 | ||
| 0.142 | 0.021 | 0.142 | Histidine decarboxylase inhibitor | 0.142 0.021 DBMET01540 | ||
| 0.159 | 0.039 | 0.159 | Adenylate cyclase inhibitor | 0.137 0.054 DBMET01540 | ||
| 0.16 | 0.042 | 0.16 | Aldehyde dehydrogenase inhibitor | 0.16 0.042 DBMET01540 | ||
| 0.169 | 0.05 | 0.178 | Hemostatic | 0.178 0.043 DBMET01540 | DBMET01540 | |
| 0.15 | 0.034 | 0.15 | Calcium channel (voltage-sensitive) blocker | 0.14 0.039 DBMET01540 | ||
| 0.208 | 0.094 | 0.208 | Antiamyloidogenic | |||
| 0.122 | 0.009 | 0.122 | Estrogen-related receptor beta agonist | 0.111 0.015 DBMET01540 | ||
| 0.163 | 0.051 | 0.163 | Histone deacetylase SIRT1 inhibitor | 0.139 0.072 DBMET01540 | ||
| 0.116 | 0.005 | 0.116 | Collagenase inhibitor | 0.047 0.038 DBMET01540 | ||
| 0.134 | 0.023 | 0.134 | Metalloproteinase-2 inhibitor | 0.076 0.057 DBMET01540 | ||
| 0.129 | 0.019 | 0.129 | Keratolytic | 0.104 0.028 DBMET01540 | ||
| 0.113 | 0.004 | 0.113 | Neutral endopeptidase inhibitor | 0.042 0.009 DBMET01540 | ||
| 0.133 | 0.027 | 0.133 | Alcohol dehydrogenase inhibitor | 0.125 0.032 DBMET01540 | ||
| 0.109 | 0.004 | 0.109 | Arginase inhibitor | 0.098 0.004 DBMET01540 | ||
| 0.141 | 0.035 | 0.141 | Caspase 3 inhibitor | 0.122 0.057 DBMET01540 | ||
| 0.134 | 0.031 | 0.134 | Creatine kinase inhibitor | 0.134 0.031 DBMET01540 | ||
| 0.216 | 0.115 | 0.216 | Transcription factor STAT3 inhibitor | |||
| 0.18 | 0.08 | 0.194 | Hepatoprotectant | 0.194 0.068 DBMET01540 | DBMET01540 | |
| 0.115 | 0.015 | 0.115 | GP IIb/IIIa receptor antagonist | 0.105 0.017 DBMET01540 | ||
| 0.125 | 0.026 | 0.125 | NADH dehydrogenase inhibitor | 0.125 0.026 DBMET01540 | ||
| 0.132 | 0.033 | 0.132 | Sphingomyelinase inhibitor | 0.092 0.07 DBMET01540 | ||
| 0.163 | 0.066 | 0.163 | Melanin inhibitor | 0.155 0.075 DBMET01540 | ||
| 0.106 | 0.013 | 0.106 | Vanilloid 4 agonist | 0.092 0.024 DBMET01540 | ||
| 0.104 | 0.013 | 0.104 | Caspase 9 inhibitor | 0.089 0.018 DBMET01540 | ||
| 0.11 | 0.019 | 0.11 | Neutrophil collagenase inhibitor | 0.069 0.041 DBMET01540 | ||
| 0.093 | 0.003 | 0.093 | Glutamate (mGluR8) agonist | 0.093 0.003 DBMET01540 | ||
| 0.12 | 0.031 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.055 DBMET01540 | ||
| 0.111 | 0.022 | 0.111 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 DBMET01540 | ||
| 0.091 | 0.003 | 0.091 | Kainate receptor agonist | 0.091 0.003 DBMET01540 | ||
| 0.102 | 0.014 | 0.102 | Endothelin-converting enzyme inhibitor | 0.099 0.014 DBMET01540 | ||
| 0.099 | 0.013 | 0.099 | Interferon inducer | 0.091 0.017 DBMET01540 | ||
| 0.105 | 0.02 | 0.105 | Ribonucleotide reductase inhibitor | 0.104 0.02 DBMET01540 | ||
| 0.096 | 0.012 | 0.096 | Carbonic anhydrase XIV inhibitor | 0.061 0.024 DBMET01540 | ||
| 0.091 | 0.007 | 0.091 | Squalene synthetase inhibitor | |||
| 0.116 | 0.032 | 0.116 | Aminoacyl-tRNA synthetase inhibitor | 0.1 0.045 DBMET01540 | ||
| 0.107 | 0.024 | 0.107 | Matrix metalloproteinase inhibitor | 0.079 0.037 DBMET01540 | ||
| 0.139 | 0.056 | 0.179 | DNA polymerase I inhibitor | 0.179 0.036 DBMET01540 | DBMET01540 | |
| 0.085 | 0.003 | 0.085 | Glutamate (mGluR3) agonist | 0.07 0.003 DBMET01540 | ||
| 0.101 | 0.019 | 0.101 | Ribonucleoside-diphosphate reductase inhibitor | 0.1 0.019 DBMET01540 | ||
| 0.093 | 0.012 | 0.093 | Metalloproteinase-3 inhibitor | 0.047 0.037 DBMET01540 | ||
| 0.109 | 0.028 | 0.109 | Metalloproteinase-9 inhibitor | |||
| 0.12 | 0.039 | 0.12 | Folate antagonist | 0.12 0.039 DBMET01540 | ||
| 0.087 | 0.007 | 0.087 | Adenine nucleotide translocase inhibitor | 0.08 0.009 DBMET01540 | ||
| 0.085 | 0.007 | 0.085 | Glucose-6-phosphate isomerase inhibitor | 0.085 0.007 DBMET01540 | ||
| 0.082 | 0.005 | 0.082 | Glutamate (mGluR3) antagonist | 0.067 0.006 DBMET01540 | ||
| 0.176 | 0.098 | 0.176 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.176 0.098 DBMET01540 | ||
| 0.101 | 0.024 | 0.101 | Sphingosine 1-phosphate receptor 4 agonist | 0.091 0.029 DBMET01540 | ||
| 0.09 | 0.015 | 0.09 | Exportin-1 inhibitor | 0.084 0.021 DBMET01540 | ||
| 0.102 | 0.027 | 0.102 | Selectin antagonist | |||
| 0.08 | 0.005 | 0.08 | GABA uptake inhibitor | 0.066 0.008 DBMET01540 | ||
| 0.086 | 0.011 | 0.086 | Angiotensin-converting enzyme inhibitor | 0.078 0.015 DBMET01540 | ||
| 0.097 | 0.023 | 0.097 | Glucagon-like peptide 1 agonist | 0.061 0.048 DBMET01540 | ||
| 0.082 | 0.007 | 0.082 | Retinoid X receptor agonist | 0.071 0.01 DBMET01540 | ||
| 0.075 | 0.003 | 0.075 | Integrin alpha1beta1 antagonist | 0.072 0.004 DBMET01540 | ||
| 0.089 | 0.017 | 0.089 | Matrix metalloproteinase (membrane-type) inhibitor | 0.055 0.038 DBMET01540 | ||
| 0.148 | 0.077 | 0.148 | Insulin secretagoues | 0.121 0.11 DBMET01540 | ||
| 0.102 | 0.032 | 0.102 | Granulocyte macrophage colony stimulating factor agonist | 0.102 0.032 DBMET01540 | ||
| 0.11 | 0.041 | 0.11 | NMDA receptor antagonist | |||
| 0.085 | 0.017 | 0.085 | Neurotensin receptor antagonist | 0.054 0.026 DBMET01540 | ||
| 0.089 | 0.021 | 0.089 | Protease 3C (Human rhinovirus) inhibitor | 0.075 0.032 DBMET01540 | ||
| 0.112 | 0.044 | 0.112 | Electrolyte absorption antagonist | 0.112 0.044 DBMET01540 | ||
| 0.074 | 0.007 | 0.074 | Leukotriene D4 antagonist | |||
| 0.113 | 0.047 | 0.113 | Anabolic | 0.113 0.047 DBMET01540 | ||
| 0.073 | 0.008 | 0.073 | GABA B receptor antagonist | 0.069 0.009 DBMET01540 | ||
| 0.092 | 0.027 | 0.092 | Sirtuin 1 inhibitor | 0.078 0.037 DBMET01540 | ||
| 0.137 | 0.072 | 0.137 | Neurotrophic factor | |||
| 0.086 | 0.021 | 0.086 | NMDA 2C receptor antagonist | 0.07 0.033 DBMET01540 | ||
| 0.201 | 0.137 | 0.201 | Transcription factor STAT inhibitor | |||
| 0.083 | 0.019 | 0.083 | Antimetabolite | 0.071 0.021 DBMET01540 | ||
| 0.083 | 0.019 | 0.083 | Integrin antagonist | 0.056 0.025 DBMET01540 | ||
| 0.087 | 0.024 | 0.087 | NMDA receptor glycine site agonist | 0.079 0.029 DBMET01540 | ||
| 0.072 | 0.009 | 0.072 | Retinoid X alpha receptor agonist | 0.056 0.012 DBMET01540 | ||
| 0.072 | 0.008 | 0.072 | Kainate receptor 2 antagonist | 0.059 0.012 DBMET01540 | ||
| 0.104 | 0.041 | 0.104 | Bile acid receptor antagonist | 0.1 0.05 DBMET01540 | ||
| 0.076 | 0.013 | 0.076 | Alpha-mannosidase inhibitor | 0.07 0.017 DBMET01540 | ||
| 0.118 | 0.056 | 0.118 | Chelator | |||
| 0.073 | 0.011 | 0.073 | Mannosidase inhibitor | 0.067 0.013 DBMET01540 | ||
| 0.121 | 0.059 | 0.121 | Microtubule formation inhibitor | 0.111 0.073 DBMET01540 | ||
| 0.145 | 0.084 | 0.145 | Interferon gamma antagonist | 0.145 0.084 DBMET01540 | ||
| 0.071 | 0.01 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.055 0.038 DBMET01540 | ||
| 0.113 | 0.052 | 0.113 | Carbonic anhydrase XV inhibitor | 0.097 0.071 DBMET01540 | ||
| 0.23 | 0.172 | 0.23 | Calcium channel activator | 0.23 0.172 DBMET01540 | ||
| 0.067 | 0.008 | 0.067 | AMPA 4 receptor antagonist | 0.057 0.011 DBMET01540 | ||
| 0.064 | 0.006 | 0.064 | Peptide deformylase inhibitor | 0.055 0.008 DBMET01540 | ||
| 0.076 | 0.018 | 0.076 | Bombesin 2 receptor antagonist | 0.061 0.023 DBMET01540 | ||
| 0.103 | 0.046 | 0.103 | ABCA1 expression enhancer | 0.093 0.06 DBMET01540 | ||
| 0.112 | 0.059 | 0.112 | Falcipain 3 inhibitor | |||
| 0.066 | 0.013 | 0.066 | Leukotriene A4 hydrolase inhibitor | 0.039 0.026 DBMET01540 | ||
| 0.066 | 0.014 | 0.066 | Calcitonin receptor agonist | 0.054 0.016 DBMET01540 | ||
| 0.067 | 0.019 | 0.067 | Complement C3a chemotactic receptor antagonist | 0.056 0.024 DBMET01540 | ||
| 0.093 | 0.045 | 0.093 | Glutathione S-transferase inhibitor | 0.078 0.064 DBMET01540 | ||
| 0.125 | 0.078 | 0.168 | Amylase inhibitor | 0.168 0.056 DBMET01540 | DBMET01540 | |
| 0.062 | 0.015 | 0.062 | Oxytocin agonist | 0.057 0.019 DBMET01540 | ||
| 0.076 | 0.029 | 0.076 | Neuraminidase inhibitor | |||
| 0.054 | 0.007 | 0.054 | Glutamate (mGluR8) antagonist | 0.054 0.007 DBMET01540 | ||
| 0.179 | 0.133 | 0.179 | Antioxidant | |||
| 0.082 | 0.036 | 0.082 | Opioid delta receptor antagonist | |||
| 0.092 | 0.046 | 0.092 | Hematopoietic | 0.089 0.052 DBMET01540 | ||
| 0.061 | 0.015 | 0.061 | Kainate receptor antagonist | 0.051 0.021 DBMET01540 | ||
| 0.088 | 0.043 | 0.088 | Somatostatin 1 agonist | 0.088 0.043 DBMET01540 | ||
| 0.065 | 0.02 | 0.065 | Sphingosine 1-phosphate receptor 5 agonist | 0.063 0.022 DBMET01540 | ||
| 0.105 | 0.06 | 0.105 | Factor V inhibitor | 0.105 0.06 DBMET01540 | ||
| 0.059 | 0.014 | 0.059 | Geranyltranstransferase inhibitor | 0.053 0.02 DBMET01540 | ||
| 0.09 | 0.046 | 0.09 | Vanilloid agonist | |||
| 0.078 | 0.034 | 0.078 | Leukotriene antagonist | |||
| 0.057 | 0.013 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DBMET01540 | ||
| 0.058 | 0.015 | 0.058 | Glutamate (mGluR4) antagonist | 0.058 0.015 DBMET01540 | ||
| 0.056 | 0.014 | 0.383 | Renin inhibitor | 0.383 0.003 DBMET01540 | DBMET01540 | |
| 0.068 | 0.027 | 0.068 | Matrix metalloproteinase 1 inhibitor | |||
| 0.071 | 0.031 | 0.071 | Prostaglandin F2 alpha antagonist | 0.067 0.035 DBMET01540 | ||
| 0.044 | 0.004 | 0.044 | Aminopeptidase A inhibitor | 0.038 0.005 DBMET01540 | ||
| 0.056 | 0.017 | 0.056 | AICAR transformylase inhibitor | 0.052 0.021 DBMET01540 | ||
| 0.05 | 0.012 | 0.05 | Caspase 2 inhibitor | 0.043 0.014 DBMET01540 | ||
| 0.054 | 0.016 | 0.054 | Neurokinin 2 agonist | 0.044 0.025 DBMET01540 | ||
| 0.16 | 0.123 | 0.16 | Neurotrophic factor enhancer | 0.16 0.123 DBMET01540 | ||
| 0.073 | 0.037 | 0.073 | Glutamate (mGluR7) antagonist | 0.073 0.037 DBMET01540 | ||
| 0.069 | 0.034 | 0.069 | Nitric oxide donor | |||
| 0.084 | 0.049 | 0.084 | Chymotrypsin inhibitor | |||
| 0.044 | 0.01 | 0.044 | ATP citrate lysase inhibitor | 0.037 0.016 DBMET01540 | ||
| 0.145 | 0.111 | 0.145 | ATPase inhibitor | |||
| 0.074 | 0.04 | 0.09 | Protein kinase C alpha inhibitor | 0.09 0.027 DBMET01540 | DBMET01540 | |
| 0.063 | 0.029 | 0.063 | Protein 50S ribosomal subunit inhibitor | 0.049 0.041 DBMET01540 | ||
| 0.052 | 0.018 | 0.052 | Glutamate (mGluR group III) antagonist | 0.052 0.018 DBMET01540 | ||
| 0.058 | 0.025 | 0.058 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.03 DBMET01540 | ||
| 0.084 | 0.051 | 0.084 | Glycine receptor antagonist | 0.084 0.051 DBMET01540 | ||
| 0.092 | 0.06 | 0.092 | Protein kinase C delta inhibitor | 0.079 0.078 DBMET01540 | ||
| 0.043 | 0.01 | 0.043 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DBMET01540 | ||
| 0.039 | 0.007 | 0.039 | Kainate receptor 1 antagonist | 0.03 0.01 DBMET01540 | ||
| 0.06 | 0.028 | 0.06 | Thromboxane synthase inhibitor | 0.055 0.037 DBMET01540 | ||
| 0.043 | 0.012 | 0.043 | Glucagon receptor antagonist | 0.028 0.023 DBMET01540 | ||
| 0.084 | 0.053 | 0.084 | Carbonic anhydrase VI inhibitor | 0.074 0.065 DBMET01540 | ||
| 0.089 | 0.058 | 0.089 | Opioid antagonist | |||
| 0.035 | 0.004 | 0.035 | Carbonic anhydrase VIII inhibitor | 0.035 0.004 DBMET01540 | ||
| 0.035 | 0.004 | 0.035 | Carbonic anhydrase X inhibitor | 0.035 0.004 DBMET01540 | ||
| 0.05 | 0.02 | 0.054 | Sphingosine 1-phosphate receptor 1 agonist | 0.054 0.016 DBMET01540 | DBMET01540 | |
| 0.107 | 0.076 | 0.107 | TRPA1 agonist | 0.107 0.076 DBMET01540 | ||
| 0.057 | 0.027 | 0.057 | Carbonic anhydrase II stimulant | 0.055 0.03 DBMET01540 | ||
| 0.034 | 0.004 | 0.034 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 DBMET01540 | ||
| 0.102 | 0.074 | 0.102 | Cystathionine beta-synthase inhibitor | 0.102 0.074 DBMET01540 | ||
| 0.107 | 0.079 | 0.107 | Proteasome inhibitor | |||
| 0.096 | 0.068 | 0.096 | Glutamate (mGluR7) agonist | 0.096 0.068 DBMET01540 | ||
| 0.035 | 0.007 | 0.035 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.054 | 0.028 | 0.054 | HCV NS3/NS4A protease inhibitor | 0.048 0.035 DBMET01540 | ||
| 0.033 | 0.007 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 DBMET01540 | ||
| 0.03 | 0.005 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 DBMET01540 | ||
| 0.071 | 0.046 | 0.071 | Opioid mu receptor antagonist | |||
| 0.032 | 0.009 | 0.032 | Glutamate (mGluR1) agonist | 0.032 0.009 DBMET01540 | ||
| 0.062 | 0.039 | 0.062 | Collagenase 3 inhibitor | |||
| 0.032 | 0.009 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.032 0.009 DBMET01540 | ||
| 0.045 | 0.023 | 0.045 | Integrin alpha5beta1 antagonist | 0.044 0.024 DBMET01540 | ||
| 0.058 | 0.036 | 0.058 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.058 0.036 DBMET01540 | ||
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | 0.033 0.012 DBMET01540 | ||
| 0.032 | 0.011 | 0.032 | Prostaglandin H2 antagonist | 0.026 0.017 DBMET01540 | ||
| 0.106 | 0.084 | 0.106 | Interleukin 8 antagonist | |||
| 0.025 | 0.004 | 0.025 | Methylmalonyl-CoA mutase inhibitor | 0.025 0.004 DBMET01540 | ||
| 0.042 | 0.022 | 0.042 | Aggrecanase 1 inhibitor | 0.037 0.033 DBMET01540 | ||
| 0.039 | 0.02 | 0.039 | ATM kinase inhibitor | |||
| 0.051 | 0.032 | 0.051 | Factor III inhibitor | 0.051 0.032 DBMET01540 | ||
| 0.071 | 0.052 | 0.071 | Epoxide hydrolase inhibitor | |||
| 0.025 | 0.006 | 0.025 | KiSS-1 receptor antagonist | |||
| 0.08 | 0.062 | 0.09 | Inducible nitric-oxide synthase inhibitor | 0.09 0.047 DBMET01540 | DBMET01540 | |
| 0.041 | 0.023 | 0.041 | Cholecystokinin B agonist | 0.035 0.029 DBMET01540 | ||
| 0.037 | 0.019 | 0.037 | HMG CoA reductase inhibitor | 0.036 0.021 DBMET01540 | ||
| 0.046 | 0.028 | 0.049 | Sphingosine 1-phosphate receptor agonist | 0.049 0.025 DBMET01540 | DBMET01540 | |
| 0.17 | 0.153 | 0.17 | RNA-directed DNA polymerase inhibitor | |||
| 0.028 | 0.01 | 0.028 | Prostaglandin F2 alpha agonist | 0.028 0.01 DBMET01540 | ||
| 0.028 | 0.011 | 0.028 | Vitronectin receptor antagonist | 0.018 0.017 DBMET01540 | ||
| 0.046 | 0.029 | 0.046 | Parathyroid hormone antagonist | |||
| 0.027 | 0.01 | 0.027 | Glutamate (mGluR1a) agonist | 0.027 0.01 DBMET01540 | ||
| 0.022 | 0.005 | 0.022 | Telomerase stimulant | 0.022 0.005 DBMET01540 | ||
| 0.11 | 0.094 | 0.11 | Sphingosine 1-phosphate receptor 4 antagonist | 0.106 0.105 DBMET01540 | ||
| 0.026 | 0.01 | 0.026 | Integrin alphaVbeta3 antagonist | 0.025 0.011 DBMET01540 | ||
| 0.057 | 0.042 | 0.057 | Botulinum neurotoxin type A inhibitor | |||
| 0.102 | 0.086 | 0.102 | Alkylator | |||
| 0.045 | 0.03 | 0.045 | NMDA receptor subunit 3B antagonist | 0.042 0.032 DBMET01540 | ||
| 0.019 | 0.004 | 0.019 | Glutamate (mGluR6) agonist | 0.019 0.004 DBMET01540 | ||
| 0.046 | 0.031 | 0.046 | Neuraminidase (Influenza A) inhibitor | |||
| 0.025 | 0.011 | 0.025 | Integrin beta5 antagonist | 0.025 0.011 DBMET01540 | ||
| 0.054 | 0.04 | 0.054 | Neuropeptide agonist | |||
| 0.033 | 0.018 | 0.033 | Plasmepsin I inhibitor | |||
| 0.032 | 0.019 | 0.032 | AMPA 3 receptor antagonist | 0.027 0.022 DBMET01540 | ||
| 0.126 | 0.113 | 0.126 | GABA C receptor rho-2 antagonist | 0.126 0.113 DBMET01540 | ||
| 0.018 | 0.005 | 0.018 | Integrin beta6 antagonist | 0.018 0.005 DBMET01540 | ||
| 0.022 | 0.01 | 0.022 | Caspase 8 inhibitor | 0.019 0.015 DBMET01540 | ||
| 0.04 | 0.028 | 0.04 | Erythropoietin receptor agonist | |||
| 0.024 | 0.011 | 0.024 | Integrin beta3 antagonist | 0.021 0.013 DBMET01540 | ||
| 0.022 | 0.01 | 0.022 | Integrin alphaVbeta1 antagonist | 0.02 0.011 DBMET01540 | ||
| 0.022 | 0.011 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET01540 | ||
| 0.037 | 0.026 | 0.037 | 5-Alpha-reductase inhibitor | |||
| 0.057 | 0.045 | 0.07 | Cathepsin E inhibitor | 0.07 0.029 DBMET01540 | DBMET01540 | |
| 0.031 | 0.02 | 0.031 | Caspase 6 inhibitor | |||
| 0.042 | 0.031 | 0.042 | Glutamate (mGluR group III) agonist | 0.038 0.036 DBMET01540 | ||
| 0.069 | 0.059 | 0.069 | CDC25A inhibitor | |||
| 0.045 | 0.035 | 0.045 | Thymidylate synthase inhibitor | 0.043 0.037 DBMET01540 | ||
| 0.053 | 0.044 | 0.053 | Cathepsin B inhibitor | |||
| 0.035 | 0.027 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.03 DBMET01540 | ||
| 0.079 | 0.071 | 0.079 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.027 | 0.019 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.022 DBMET01540 | ||
| 0.037 | 0.029 | 0.037 | Retinoid X receptor antagonist | 0.036 0.031 DBMET01540 | ||
| 0.065 | 0.057 | 0.065 | MDM2 inhibitor | |||
| 0.079 | 0.071 | 0.079 | D-Ala-D-Ala ligase inhibitor | 0.079 0.071 DBMET01540 | ||
| 0.046 | 0.039 | 0.046 | Dopamine beta hydroxylase inhibitor | 0.046 0.039 DBMET01540 | ||
| 0.016 | 0.008 | 0.016 | Integrin alphaVbeta6 antagonist | 0.014 0.011 DBMET01540 | ||
| 0.021 | 0.014 | 0.021 | Neurokinin 1 agonist | 0.018 0.016 DBMET01540 | ||
| 0.058 | 0.051 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.038 | 0.032 | 0.038 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.108 | 0.102 | 0.108 | Antibacterial (Helicobacter pylori) | |||
| 0.033 | 0.027 | 0.033 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET01540 | ||
| 0.027 | 0.021 | 0.027 | Hedgehog signaling activator | |||
| 0.035 | 0.029 | 0.035 | Carbonic anhydrase I stimulant | |||
| 0.027 | 0.021 | 0.027 | Thrombin receptor antagonist | |||
| 0.033 | 0.027 | 0.033 | Retinoid X alpha receptor antagonist | 0.031 0.029 DBMET01540 | ||
| 0.035 | 0.029 | 0.035 | NMDA receptor subunit 3A antagonist | |||
| 0.039 | 0.034 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.034 DBMET01540 | ||
| 0.025 | 0.02 | 0.025 | Urotensin II agonist | 0.025 0.02 DBMET01540 | ||
| 0.033 | 0.028 | 0.033 | HCV polyprotein inhibitor | |||
| 0.048 | 0.044 | 0.048 | Thromboxane antagonist | |||
| 0.014 | 0.01 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.085 | 0.081 | 0.085 | UDP-glucose 4-epimerase inhibitor | 0.085 0.081 DBMET01540 | ||
| 0.03 | 0.027 | 0.03 | Dipeptidyl peptidase II inhibitor | |||
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | |||
| 0.025 | 0.022 | 0.025 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.025 0.022 DBMET01540 | ||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | 0.015 0.012 DBMET01540 | ||
| 0.031 | 0.029 | 0.031 | Calpain 1 inhibitor | |||
| 0.045 | 0.043 | 0.045 | Cytokine production stimulant | |||
| 0.043 | 0.042 | 0.043 | Thromboxane A2 antagonist | |||
| 0.021 | 0.02 | 0.021 | Aminopeptidase P inhibitor | |||
| 0.067 | 0.066 | 0.067 | Analgesic, opioid | |||
| 0.032 | 0.034 | 0.035 | Kinesin-like protein 1 inhibitor | 0.035 0.028 DBMET01540 | DBMET01540 | |
| 0.032 | 0.034 | 0.035 | Kinesin antagonist | 0.035 0.028 DBMET01540 | DBMET01540 | |
| 0.03 | 0.033 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.032 0.029 DBMET01540 | DBMET01540 | |
| 0.036 | 0.04 | 0.04 | Leukocyte elastase inhibitor | 0.04 0.034 DBMET01540 | DBMET01540 | |
| 0.043 | 0.052 | 0.048 | Human rhinovirus A protease inhibitor | 0.048 0.045 DBMET01540 | DBMET01540 | |
| 0.221 | 0.248 | 0.503 | Apoptosis agonist | 0.503 0.073 DBMET01540 | DBMET01540 | |
| 0.076 | 0.105 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.084 DBMET01540 | DBMET01540 | |
| 0.11 | 0.156 | 0.128 | Nitric oxide antagonist | 0.128 0.123 DBMET01540 | DBMET01540 | |
| 0.086 | 0.198 | 0.131 | Farnesoid X receptor antagonist | 0.131 0.081 DBMET01540 | DBMET01540 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |